Diagnostic work-up, advanced in-hospital treatment and selected post-discharge medications for the 2523 patients with acute myocarditis
| Variable | n (%) |
| Diagnostic modality | |
| CCTA | 144 (5.7) |
| CAG | 1137 (45.1) |
| PET-CT | 9 (0.4) |
| CMR | 214 (8.5) |
| EMB | 98 (3.9) |
| PET-CT or CMR or EMB | 285 (11.3) |
| CMR or EMB | 283 (11.2) |
| In-hospital advanced care | |
| ICU admission | 182 (7.2) |
| Inotropic agent use | 112 (4.4) |
| ECMO | 16 (0.6) |
| IABP | 9 (0.4) |
| T-LVAD | 4 (0.2) |
| Post-discharge medication | |
| NSAID | 455 (18.0) |
| Colchicin | 45 (1.8) |
| Steroid | 133 (5.3) |
| ACEi/ARB | 658 (26.1) |
| Beta-blocker | 761 (30.2) |
ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin-II receptor blocker; CAG, coronary angiogram; CCTA, coronary CT angiography; CMR, cardiac magnetic resonance; ECMO, extracorporeal membrane oxygenation; EMB, endomyocardial biopsy; IABP, intra-aortic balloon pump; ICU, intensive care unit; NSAID, non-steroidal anti-inflammatory drug; PET-CT, positron emission tomography CT; T-LVAD, temporary left ventricular assist device.